Objectives. To establish the characteristics of clinical manifestations and cognitive tests in patients with schizophrenia with a predominance of cognitive and negative disorders. Materials and methods. A total of 76 patients were examined (66 in the study group, 10 in the reference group), who were undergoing treatment at the Alekseev Psychiatric Clinical Hospital No. 1 (Moscow) and the Gannushkin Psychiatric Clinical Hospital No. 4 (Moscow). Clinical-psychopathological, psychometric, and statistical methods were used. Cognitive functioning was assessed using the Frontal Assessment Battery (FAB) and the Edinburgh Amyotrophic Lateral Sclerosis Behavioral and Cognitive Assessment Scale (ECAS). Emotional intelligence was assessed using the Ekman Facial Emotion Recognition (EFER) test. Results. Patients with schizophrenia showed dominance of one of three types of deficit symptoms: cognitive, emotional, or volitional. Cognitive functions decreased significantly in patients with schizophrenia as compared with the reference group (mean FAB score (M ± SD) 13.44 ± 2.97 in patients with schizophrenia vs. 16.10 ± 1.70 in the reference group; t = 4.10; p < 0.001). Cognitive functions were particularly decreased in patients with volitional deficits (mean total score on the EFER scale 42.40 ± 9.0 in patients with volitional deficits vs. 47.21 ± 6.33 in patients with cognitive deficits; t = 2.12; p = 0039; mean scores on the FAB scale were 12.83 ± 3.29 in patients with volitional deficiency vs. 16.10 ± 1.70 in patients in the reference group; p < 0.001; mean scores on the ECAS, which is specific for ALS, were 78.80 ± 9.07 in patients with volitional deficiency and 84.50 ± 6.71 in patients from the reference group; t = 2.18; p = 0.034). Conclusions. The greatest contribution to the development of cognitive impairment in schizophrenia was made by dysfunction of the frontal (especially) and temporal cortex. Executive functions, language skills, and verbal fluency were the most affected.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
R. S. E. Keefe and W. S. Fenton, “How should DSM-V criteria for schizophrenia include cognitive impairment?” Schizophr. Bull., 33, No. 4, 912–920 (2007), https://doi.org/10.1093/schbul/sbm046.
A. V. Pavlichenko, M. A. Kulygina, and G. P. Kostyuk, “Schizophrenia and other psychotic disorders in ICD-11 and DSM-5: development of concepts and current status,” Zh. Nevrol. Psikhiatr., 120, No. 6, 5–12 (2020), https://doi.org/10.17116/jnevro20201200625.
ICD-11. Chapter 06. Mental and Behavioral Disorders and Neuropsychological Development Disorders. Statistical Classification, KDU, Universitetskaya Kniga, Moscow (2021), https://doi.org/10.31453/kdu.ru.91304.0143.
Q. Wu, X. Wang, Y. Wang, et al., “Developments in biological mechanisms and treatments for negative symptoms and cognitive dysfunction of schizophrenia,” Neurosci. Bull., 37, 1609–1624 (2021), https://doi.org/10.1007/s12264-021-00740-6.
K. H. Nuechterlein and M. F. Green, “The MATRICS consensus cognitive battery, Part 1: Test selection, reliability, and validity,” Am. J. Psychiatry, 165, 203–213 (2008), https://doi.org/10.1176/appi.ajp.2007.07010042.
P. D. Harvey and R. S. E. Keefe, Clinical Neuropsychology of Schizophrenia, Oxford University Press (2009).
S. Kalkstein, I. Hurford, and R. C. Gur, “Neurocognition in schizophrenia,” Curr. Top. Behav. Neurosci., 4, 373–390 (2010), https://doi.org/10.1007/7854_2010_42.
M. D. Bell, H. W. Tsang, T. C. Greig, et al., “Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia,” Schizophr. Bull., 35, 738–747 (2009), https://doi.org/10.1093/schbul/sbm169.
J. Schaefer, E. Giangrande, D. R. Weinberger, et al., “The global cognitive impairment in schizophrenia: consistent over decades and around the world,” Schizophr. Res., 150, No. 1, 42–50 (2013), https://doi.org/10.1016/j.schres.2013.07.009.
S. M. Stahl, Stahl’s Essential Psychopharmacology. Neuroscientific Basis [Russian translation], GEOTAR-Media, Moscow (2019).
A. J. Fett, W. Viechtbauer, M. D. Dominguez, et al., “The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis,” Neurosci. Biobehav. Rev., 35, No. 3, 573–588 (2011), https://doi.org/10.1016/j.neubiorev.2010.07.001.
E. Antonova, T. Sharma, R. Morris, et al., “The relationship between brain structure and neurocognition in schizophrenia: a selective review,” Schizophr. Res., 70, No. 2–3, 117–145 (2014), https://doi.org/10.1016/j.schres.2003.12.002.
M. V. Karyakina, O. V. Rychkova, and A. B. Shmukler, “Cognitive impairment in schizophrenia in foreign studies: impairment of individual functions or a group of syndromes?” Sovremen. Zarubezhn. Psikhol. (online resource), 10, No. 2, 8–19 (2021), https://doi.org/10.17759/jmfp.2021100201.
Eric Yu-Hai Chen, Christy Lai-Ming Hui, Eva Lai-Wah Dunn, et al., “A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients,” Schizophr. Res., 77, No. 1, 99–104 (2005), https://doi.org/10.1016/j.schres.2005.02.020.
D. G. Robinson, M. G. Woerner, J. M. J. Alvir, et al., “Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder,” Am. J. Psychiatry, 156, No. 4, 544–549 (1999), https://doi.org/10.1176/ajp.156.4.544.
J. E. Overall and D. R. Gorham, “The brief psychiatric rating scale,” Psychol. Rep., 10, No. 3, 799–812 (1962), https://doi.org/10.2466/pr0.1962.10.3.799.
B. Kirkpatrick, G. P. Strauss, L. Nguyen, et al., “The brief negative symptom scale: psychometric properties,” Schizophr. Bull., 37, No. 2, 300–305 (2011), https://doi.org/10.1093/schbul/sbq059.
H. F. Goldman, A. E. Skodol, and T. R. Lave, “Reviewing axis V for the DSM-IV: A review of measures of social functioning,” Am. J. Psychiatry, 149, 148–1156 (1992), https://doi.org/10.1176/ajp.149.9.1148.
B. Dubois, A. Slachevsky, I. Litvan, et al., “The FAB: a frontal assessment battery at bedside,” Neurology, 55, No. 11, 1621–1626 (2000), https://doi.org/10.1212/WNL.55.11.1621.
P. Ekman and W. V. Friesen, “Measuring facial movement,” Environ. Psychol. Behav. Neurosci., 1, 56–75 (1976), https://doi.org/10.1007/BF01115465.
S. Abrahams, J. Newton, E. Niven, et al., “Screening for cognition and behaviour changes in ALS,” Amyotroph. Lateral Scler. Frontotemporal Degener., 15, No. 1–2, 9–14 (2014), https://doi.org/10.3109/21678421.2013.805784.
I. Nimatoudis et al., “The frontal assessment battery at bedside (FAB) in patients with schizophrenia,” Eur. Psychiatry, 22, No. 1, 128 (2007), https://doi.org/10.1016/j.eurpsy.2007.01.411.
E. Alkan, G. Davies, and S. L. Evans, “Cognitive impairment in schizophrenia: relationships with cortical thickness in fronto-temporal regions, and dissociability from symptom severity,” NPJ Schizophr., 7, No. 1, 20 (2021), https://doi.org/10.1038/s41537-021-00149-0.
M. W. Menkes, K. “Armstrong, J. U. Blackford, et al., “Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder,” Schizophr. Res., 206, 413–419 (2019), https://doi.org/10.1016/j.schres.2018.10.009.
C. R. Bowie and P. D. Harvey, “Cognition in schizophrenia: impairments, determinants, and functional importance,” Psychiatric Clinics, 28, No. 3, 613–633 (2005), https://doi.org/10.1016/j.psc.2005.05.004.
K. A. Drozdova, G. E. Rupchev, and N. D. Semenova, “Impaired verbal fluency in patients with schizophrenia,” Sotsial. Klin. Psikhiatr., 25, No. 4, 9–19 (2015).
C. McMillan, J. Wuu, K. Rascovsky, et al., “Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches,” Amyotroph. Lateral Scler. Frontotemp. Degener., 23, No. 7–8, 517–526 (2022), https://doi.org/10.1080/21678421.2022.2039713.
N. N. Koberskaya, D. A. Grishina, and N. N. Yakhno, “Amyotrophic lateral sclerosis syndrome-Alzheimer’s dementia,” Ross. Nevrol. Zh., 26, No. 2, 17–24 (2021), https://doi.org/10.30629/2658-7947-2021-26-2-17-24.
S. M. Sthal and D Morrisette, Stahl’s Illustrated. Alzheimer’s Disease and Other Dementias [Russian translation], GEOTAR Media, Moscow (2021).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 124, No. 4, Iss. 2, pp. 64–71, April, 2024.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chugunov, D.A., Shmilovich, A.A., Larina, M.R. et al. Clinical and Psychometric Features of Cognitive and Negative Disorders in Schizophrenia. Neurosci Behav Physi 54, 859–865 (2024). https://doi.org/10.1007/s11055-024-01688-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-024-01688-6